Ovarian cancer cells with the CD117 phenotype are highly tumorigenic and are related to chemotherapy outcome (Q39725023)

14 September 2017

title

Ovarian cancer cells with the CD117 phenotype are highly tumorigenic and are related to chemotherapy outcome (English)

1 reference

14 September 2017

1 reference

1 reference

Lijing Luo

1 reference

14 September 2017

Jianfang Zeng

1 reference

14 September 2017

Bing Liang

1 reference

14 September 2017

Zhe Zhao

1 reference

14 September 2017

Lulu Sun

1 reference

14 September 2017

Dongyan Cao

1 reference

14 September 2017

Jiaxin Yang

1 reference

14 September 2017

Keng Shen

1 reference

14 September 2017

publication date

20 July 2011

1 reference

Experimental and Molecular Pathology

14 September 2017

published in

1 reference

14 September 2017

1 reference

14 September 2017

1 reference

14 September 2017

page(s)

596-602

1 reference

Prospective identification of tumorigenic breast cancer cells

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

Therapeutic implications of cancer stem cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

Induction of stem cell factor/c-Kit/slug signal transduction in multidrug-resistant malignant mesothelioma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

Molecular portraits of intratumoral heterogeneity in human ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

Somatic activation of KIT in distinct subtypes of melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

Phenotypic characterization of human colorectal cancer stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

Tumour stem cells and drug resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

Biology of gastrointestinal stromal tumors: KIT mutations and beyond

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

Identification and expansion of the tumorigenic lung cancer stem cell population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

c-Kit expression in human normal and malignant stem cells prognostic and therapeutic implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

Adult bone-marrow stem cells and their potential in medicine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

Ovarian dysgerminomas are characterised by frequent KIT mutations and abundant expression of pluripotency markers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

A cell initiating human acute myeloid leukaemia after transplantation into SCID mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

Elimination of human lung cancer stem cells through targeting of the stem cell factor-c-kit autocrine signaling loop

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

Normal stem cells and cancer stem cells: the niche matters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

Identification of pancreatic cancer stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

Involvement of tyrosine kinase signaling in maintaining murine embryonic stem cell functionality.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

Recent advances in immunohistochemistry in the diagnosis of ovarian neoplasms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

The side population of ovarian cancer cells is a primary target of IFN-alpha antitumor effects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

Analysis of c-kit protein expression in small-cell lung carcinoma and its implication for prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

A human colon cancer cell capable of initiating tumour growth in immunodeficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

Treatment goals in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

Correlation of murine embryonic stem cell gene expression profiles with functional measures of pluripotency.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

c-KIT expression and correlation with chemotherapy resistance in ovarian carcinoma: an immunocytochemical study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

Stem cells, cancer, and cancer stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

Identification and expansion of human colon-cancer-initiating cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

Identification of cells initiating human melanomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

Identification of human brain tumour initiating cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

Frequent KIT and epidermal growth factor receptor overexpressions in undifferentiated-type breast carcinomas with 'stem-cell-like' features

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

Significance of CD90+ cancer stem cells in human liver cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

The stem cell factor/c-kit receptor pathway enhances proliferation and invasion of pancreatic cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

Stem cell factor/c-kit receptor signaling enhances the proliferation and invasion of colorectal cancer cells through the PI3K/Akt pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

Identification and characterization of ovarian cancer-initiating cells from primary human tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.06.005

10.1016/J.YEXMP.2011.06.005

7 January 2021

Identifiers

DOI

1 reference

14 September 2017

1 reference